XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA $ 3,204 $ 7,109
Interest expense, net 1,289 375
Depreciation and amortization 12,670 7,516
Share-based compensation expense 13,020 4,332
Foreign exchange impact (583) 1,242
SeaSpine merger-related costs 20,740  
Strategic investments 661 970
Acquisition-related fair value adjustments 11,636 (5,500)
Legal judgments/settlements 469 193
Medical device regulation 3,629 1,952
Business interruption - COVID-19   343
All other   75
Loss before income taxes (60,327) (4,389)
Operating Segments [Member] | Global Spine [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA 14,981 14,033
Operating Segments [Member] | Global Orthopedics [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA 44 (804)
Corporate, Non-Segment [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA $ (11,821) $ (6,120)